# The Effects of ACTH and Dexamethasone on the Transcriptomic Profile of the Rat Adrenal Gland: An In Vivo Study

**Authors:** Emilia Cicha, Małgorzata Blatkiewicz, Karol Jopek, Marta Szyszka, Piotr W. Malendowicz, Anna Olechnowicz, Ludwik K. Malendowicz, Marcin Rucinski

PMC · DOI: 10.3390/cimb48020135 · 2026-01-27

## TL;DR

This study explores how ACTH and Dexamethasone affect gene activity in rat adrenal glands, revealing distinct responses to acute and prolonged stress signals.

## Contribution

The study identifies distinct transcriptional programs triggered by acute ACTH stimulation versus prolonged ACTH exposure and Dexamethasone treatment in rat adrenal glands.

## Key findings

- Acute ACTH exposure activates immediate-early genes and stress-related pathways like cAMP-PKA-CREB signaling.
- Prolonged ACTH exposure suppresses mitochondrial genes and activates epigenetic repression mechanisms.
- Dexamethasone inhibits cholesterol metabolism pathways via suppression of the SREBP pathway.

## Abstract

The hypothalamic–pituitary–adrenal (HPA) axis plays a pivotal role in regulating stress responses through ACTH-stimulated glucocorticoid production. The transcriptional programmes underlying temporal adaptation to prolonged ACTH exposure and glucocorticoid feedback remain incompletely characterized. Adult male Wistar rats were subjected to acute ACTH stimulation (single injection, 1 h) to elicit an immediate transcriptional response, prolonged ACTH exposure (three injections over 36 h) as a repeated exposure, or Dexamethasone treatment (three injections over 36 h). Plasma corticosterone levels were subsequently measured using an enzyme-linked immunosorbent assay (ELISA). The adrenal transcriptome profiling was performed using Affymetrix arrays. Differentially expressed genes (DEGs; |fold change| ≥ 1.8, adjusted p < 0.05) were analyzed using limma, followed by pathway and network analyses. Acute ACTH exposure resulted in the induction of 569 DEGs (357 upregulated), including immediate-early genes (Nr4a family, AP-1 factors), cAMP-PKA-CREB signalling components, and heat shock proteins. Prolonged ACTH resulted in 98 DEGs (predominantly downregulated), including the suppression of mitochondrial genes and upregulation of Polycomb repressive complex 2 components, suggesting epigenetic transcriptional attenuation. Dexamethasone treatment yielded 75 DEGs with selective suppression of SREBP-mediated cholesterol biosynthesis and uptake pathways. Twelve genes were downregulated by both prolonged ACTH and Dexamethasone, including sterol metabolism and interferon-stimulated genes. Acute and prolonged ACTH exposure engage distinct transcriptional programmes. Acute stimulation activates immediate-early genes and stress responses, while prolonged exposure suppresses mitochondrial gene expression through transcriptional dampening mechanisms. Dexamethasone is associated with the inhibition of cholesterol metabolism via SREBP pathway suppression. These findings illuminate HPA axis adaptation and glucocorticoid-induced adrenal suppression.

## Linked entities

- **Genes:** FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353], SREBP (Sterol regulatory element binding protein) [NCBI Gene 40155]
- **Chemicals:** ACTH (PubChem CID 16129617), Dexamethasone (PubChem CID 5743), corticosterone (PubChem CID 5753)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Wnt4 (Wnt family member 4) [NCBI Gene 84426], Zfp3 (zinc finger protein 3) [NCBI Gene 497944] {aka RGD1565881}, Elovl6 (ELOVL fatty acid elongase 6) [NCBI Gene 171402] {aka Lce2, rELO2}, Zfp113 (zinc finger protein 3) [NCBI Gene 100912096], Suz12 (SUZ12 polycomb repressive complex 2 subunit) [NCBI Gene 52615] {aka 2610028O16Rik, D11Ertd530e, mKIAA0160}, Notch1 (notch receptor 1) [NCBI Gene 25496] {aka NOTCH, TAN1}, Spi1 (Spi-1 proto-oncogene) [NCBI Gene 366126] {aka Pu.1, Sfpi1}, Hspa1a (heat shock protein family A (Hsp70) member 1A) [NCBI Gene 24472] {aka HSP70-2, HSP70.1, HSP70.2, HSP72, Hsp70-1, Hspa1}, Idi1 (isopentenyl-diphosphate delta isomerase 1) [NCBI Gene 89784], E2f4 (E2F transcription factor 4) [NCBI Gene 100360427], Ldlr (low density lipoprotein receptor) [NCBI Gene 300438] {aka LDLRA}, Pou5f1 (POU class 5 homeobox 1) [NCBI Gene 294562], Srebf2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 300095] {aka SREBP-2, SREBP2, Srebf2_retired}, Zfp1 (zinc finger protein 1) [NCBI Gene 498952] {aka RGD1565049}, Tp53 (tumor protein p53) [NCBI Gene 24842] {aka Trp53, p53}, Ezh2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) [NCBI Gene 14056] {aka Enx-1, Enx1h, KMT6, mKIAA4065}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 314322] {aka c-fos}, Ets1 (ETS proto-oncogene 1, transcription factor) [NCBI Gene 24356] {aka Ets-1, Etsoncb, Tpl1}, Nr4a2 (nuclear receptor subfamily 4, group A, member 2) [NCBI Gene 18227] {aka HZF-3, NOT, Nurr1, RNR-1, TINOR, TINUR}, Nr4a3 (nuclear receptor subfamily 4, group A, member 3) [NCBI Gene 18124] {aka CHN, CSMF, MINOR, NOR-1, Nor1, TEC}, SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha) [NCBI Gene 8802] {aka GALPHA, MTDPS9, SUCLA1}, Mitf (melanocyte inducing transcription factor) [NCBI Gene 25094], Ndufa6 (NADH:ubiquinone oxidoreductase subunit A6) [NCBI Gene 315167], Foxo3 (forkhead box O3) [NCBI Gene 294515] {aka Fkhrl1, Foxo3a}, Tcf3 (transcription factor 3) [NCBI Gene 171046] {aka Pan2, Tcfe2a}, Sqle (squalene epoxidase) [NCBI Gene 29230], Vdr (vitamin D receptor) [NCBI Gene 24873] {aka Nr1i1}, Jund (JunD proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 24518], Lrat (lecithin retinol acyltransferase) [NCBI Gene 64047], Kdm5a (lysine demethylase 5A) [NCBI Gene 312678] {aka Jarid1a}, Dach1 (dachshund family transcription factor 1) [NCBI Gene 306096], MC2R (melanocortin 2 receptor) [NCBI Gene 4158] {aka ACTHR}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 24516], Ncor1 (nuclear receptor co-repressor 1) [NCBI Gene 54299] {aka Rxrip13}, Gpbar1 (G protein-coupled bile acid receptor 1) [NCBI Gene 338443] {aka M-BAR, Tgr5}, Zfp329 (zinc finger protein 329) [NCBI Gene 308361] {aka RGD1565029}, Nr4a3 (nuclear receptor subfamily 4, group A, member 3) [NCBI Gene 58853] {aka NOR-2}, Ppard (peroxisome proliferator-activated receptor delta) [NCBI Gene 25682] {aka Pparb}, Ca3 (carbonic anhydrase 3) [NCBI Gene 54232] {aka Car3}, Ntrk1 (neurotrophic receptor tyrosine kinase 1) [NCBI Gene 59109] {aka Trk}, E2f1 (E2F transcription factor 1) [NCBI Gene 399489], Gsr (glutathione-disulfide reductase) [NCBI Gene 116686], Ep300 (EP300 lysine acetyltransferase) [NCBI Gene 170915], CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, Ifnb1 (interferon beta 1) [NCBI Gene 24481] {aka If1da1, Ifnb}, Nr4a1 (nuclear receptor subfamily 4, group A, member 1) [NCBI Gene 79240] {aka HMR, Ngfi-b, Nur77}, Fli1 (Fli-1 proto-oncogene, ETS transcription factor) [NCBI Gene 315532], Avp (arginine vasopressin) [NCBI Gene 24221] {aka ADH, DI, VP, Vas}, Hoxc9 (homeobox C9) [NCBI Gene 368178] {aka Hoxc8}, Rgs2 (regulator of G-protein signaling 2) [NCBI Gene 84583], Nucks1 (nuclear casein kinase and cyclin-dependent kinase substrate 1) [NCBI Gene 64709] {aka Nucks}, Lef1 (lymphoid enhancer binding factor 1) [NCBI Gene 161452], Ddit4 (DNA-damage-inducible transcript 4) [NCBI Gene 140942] {aka Rtp801}, Zfp217 (zinc finger protein 217) [NCBI Gene 311764] {aka Znf217}, Insig1 (insulin induced gene 1) [NCBI Gene 64194], Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 24253] {aka Il6dbp, NF-IL6, TCF5}, Mrpl32 (mitochondrial ribosomal protein L32) [NCBI Gene 291206], Egr1 (early growth response 1) [NCBI Gene 24330] {aka Krox-24, NGFI-A, Ngf1, Ngfi, zif-268}, Star (steroidogenic acute regulatory protein) [NCBI Gene 20845] {aka D8Ertd419e, stARD1}, Padi4 (peptidyl arginine deiminase 4) [NCBI Gene 29512] {aka Pdi4}
- **Diseases:** inflammatory (MESH:D007249), injury to (MESH:D014947), suppression (MESH:D000550), pain (MESH:D010146), mitochondrial (MESH:D028361), pituitary adenomas (MESH:D010911), loss of consciousness (MESH:D014474), adrenal insufficiency (MESH:D000309), adrenocortical tumour (MESH:D009369), adrenal atrophy (MESH:D001284), adrenal suppression (MESH:D000310), HPA (MESH:D007029), primary adrenal insufficiency (MESH:D000224), metabolic dysfunction (MESH:D008659), immune suppression (OMIM:146850), hypercortisolism (MESH:D003480), adrenal dysfunction (MESH:D000307), adrenal hypertrophy (MESH:D006984), bone loss (MESH:D001847), Cushing's disease (MESH:D047748)
- **Chemicals:** GTP (MESH:D006160), zinc (MESH:D015032), nitrogen (MESH:D009584), cortisol (MESH:D006854), EDTA (MESH:D004492), aldosterone (MESH:D000450), Corticosterone (MESH:D003345), pregnenolone (MESH:D011284), retinoid (MESH:D012176), Biotin (MESH:D001710), Cholesterol (MESH:D002784), cyclic AMP (MESH:D000242), DEX (-), Dexamethasone (MESH:D003907), amino-acid (MESH:D000596), fatty acid (MESH:D005227), Steroid (MESH:D013256), lipid (MESH:D008055), sterol (MESH:D013261), alcohol (MESH:D000438), calcium (MESH:D002118), oxide (MESH:D010087)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** Y1 — Mus musculus (Mouse), Mouse adrenal cortical carcinoma, Cancer cell line (CVCL_0585)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939450/full.md

---
Source: https://tomesphere.com/paper/PMC12939450